SAXS/PCS study on the mesoscopic structure of lipid nanoparticle (LNP) formulations for mRNA drug delivery: Comirnaty and drug-free LNP dispersions

21 August 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Lipid Nanoparticles (LNPs) produced by anti-solvent precipitation (ASP) are used in formulations for mRNA drug delivery. The mesoscopic structure of such complex multicomponent and polydisperse nanoparticulate systems is most relevant for their drug delivery properties, medical efficiency, shelf-life, and possible side effects. However, the knowledge on the structural details of such formulations is very limited. Essentially no such information is publicly available for pharmaceutical dispersions approved by numerous medicine agencies for the use in humans and loaded with mRNA encoding a mimic of the spike protein of the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) as e.g. the Comirnaty formulation (BioNTech). Here, we present a simple preparation method to mimic the Comirnaty drug-free LNPs including a comparison of their structural properties with those of Comirnaty. Strong evidence for the liquid state of the LNPs in both systems is found in contrast to the designation of the LNPs as solid lipid nanoparticles by BioNTech. A detailed structural model for the LNPs i.a. revealing their unexpected narrow size distribution will be presented based on SAXS, DLS, light microscopy, and ¹HNMR studies. The presented results should contribute to better understanding the LNP drug delivery process, enhancing their medical benefit, and reducing side effects.

Keywords

lipid nanoparticles (LNPs)
BNT162b2
Comirnaty
small angle X-ray scattering (SAXS)
dynamic light scattering (DLS or PCS)
mRNA drug delivery
severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2)
proton nuclear magnetic resonance spectroscopy (¹HNMR)

Supplementary materials

Title
Description
Actions
Title
BNT24_video
Description
Video of optical microscopy measurement of sample BNT24.
Actions
Title
EF46_video
Description
Video of optical microscopy measurement of sample EF46.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.
Comment number 2, Sabine Stebel: Nov 20, 2023, 18:21

“Two different BNT-sample batches have been studied differing in lipid concentration by a factor of 5 and in the composition of the aqueous phase (salts and pH buffer).” - Doesn't sound like GMP production to me. Could this be a problem in the light of GMP production?

Comment number 1, Sabine Stebel: Nov 20, 2023, 17:40

The pH of some of the vials in Table 1 is below the acceptance criteria of 6.9 to 7.9. The accepted pH-range is in this document https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.covidtruths.co.uk%2Fwp-content%2Fuploads%2F2021%2F04%2FPriority-OCs-in-quality-LoQ-COVID-19-mRNA-Vaccine-BioNTech.docx&wdOrigin=BROWSELINK